187 related articles for article (PubMed ID: 15489892)
1. Inhibition of p53-mediated transcriptional responses by mithramycin A.
Koutsodontis G; Kardassis D
Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
[TBL] [Abstract][Full Text] [Related]
5. Sp1-mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway.
Bu Y; Suenaga Y; Ono S; Koda T; Song F; Nakagawara A; Ozaki T
Genes Cells; 2008 Jan; 13(1):53-66. PubMed ID: 18173747
[TBL] [Abstract][Full Text] [Related]
6. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
7. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
[TBL] [Abstract][Full Text] [Related]
8. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
9. In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.
Potratz JC; Mlody B; Berdel WE; Serve H; Müller-Tidow C
Int J Oncol; 2005 Feb; 26(2):493-8. PubMed ID: 15645135
[TBL] [Abstract][Full Text] [Related]
10. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
11. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
Laenen K; Haegeman G; Vanhoenacker P
Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
[TBL] [Abstract][Full Text] [Related]
12. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
[TBL] [Abstract][Full Text] [Related]
13. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
Cen B; Deguchi A; Weinstein IB
Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
[TBL] [Abstract][Full Text] [Related]
14. Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.
Shin T; Sumiyoshi H; Matsuo N; Satoh F; Nomura Y; Mimata H; Yoshioka H
Arch Biochem Biophys; 2005 Mar; 435(2):291-302. PubMed ID: 15708372
[TBL] [Abstract][Full Text] [Related]
15. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
[TBL] [Abstract][Full Text] [Related]
16. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
[TBL] [Abstract][Full Text] [Related]
17. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
19. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
Wang CH; Chang HC; Hung WC
J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
[TBL] [Abstract][Full Text] [Related]
20. Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers.
Ohgami T; Kato K; Kobayashi H; Sonoda K; Inoue T; Yamaguchi S; Yoneda T; Wake N
Cancer Sci; 2010 Jun; 101(6):1387-95. PubMed ID: 20331637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
